THE ASSOCIATION BETWEEN GENETIC POLYMORPHISMS OF TOLL-LIKE RECEPTORS AND MANNOSE-BINDING LECTIN AND ACTIVE TUBERCULOSIS IN HIV-INFECTED PATIENTS
暂无分享,去创建一个
[1] Валентина Теслюк,et al. ИССЛЕДОВАНИЯ МОТИВАЦИОННОГО КОМПОНЕНТА ПРОФЕССИОНАЛЬНО-ПЕДАГОГИЧЕСКОЙ КОМПЕТЕНТНОСТИ БУДУЩИХ ПРЕПОДАВАТЕЛЕЙ УЧРЕЖДЕНИЯ ВЫСШЕГО ОБРАЗОВАНИЯ , 2018, Modern engineering and innovative technologies.
[2] M. Tremblay,et al. Interferon-β induced in female genital epithelium by HIV-1 glycoprotein 120 via Toll-like-receptor 2 pathway acts to protect the mucosal barrier , 2018, Cellular & Molecular Immunology.
[3] J. Sterne,et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies , 2017, The lancet. HIV.
[4] J. Karn,et al. Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells , 2017, Retrovirology.
[5] Д. Г. Курбатов,et al. Андрология. Фармакология без ошибок под редакцией акад.РАН Камалова А.А. руководство для врачей , 2017 .
[6] R. Mandal,et al. A Meta-analysis of MBL2 Polymorphisms and Tuberculosis Risk , 2016, Scientific Reports.
[7] G. Shipulin,et al. [The comparison of three molecular genetic techniques for identifying major mutations in gene HFE related to development of inherent hemochromatosis.] , 2016, Klinicheskaia laboratornaia diagnostika.
[8] Герман Александрович Шипулин,et al. Сравнение трех молекулярно-генетических методик для определения основных мутаций в гене HFE, связанных с развитием наследственного гемохроматоза , 2016 .
[9] С. Ю. Терещенко,et al. Дефицит маннозосвязывающего лектина при заболеваниях респираторного тракта , 2016 .
[10] PHARMACOPOEIA MONOGRAPH,et al. MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION , 2016 .
[11] Лаптев Дмитрий Никитич,et al. Федеральные клинические рекомендации по помповой инсулинотерапии и непрерывному мониторированию гликемии у больных сахарным диабетом. ПРОЕКТ , 2015 .
[12] Xu-guang Guo,et al. The rs5743708 gene polymorphism in the TLR2 gene contributes to the risk of tuberculosis disease. , 2015, International journal of clinical and experimental pathology.
[13] K. Alagarasu,et al. Immunogenetics of HIV and HIV associated tuberculosis. , 2012, Tuberculosis.
[14] S. Munsiff,et al. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[15] M. Leal,et al. The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in Caucasian HIV-infected patients. , 2010, Current HIV research.
[16] S. Swaminathan,et al. CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[17] S. Swaminathan,et al. 5′ Regulatory and 3′ Untranslated Region Polymorphisms of Vitamin D Receptor Gene in South Indian HIV and HIV–TB Patients , 2009, Journal of Clinical Immunology.
[18] S. Swaminathan,et al. Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India. , 2007, Tuberculosis.
[19] C. Rodríguez-Gallego,et al. Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population. , 2006, Molecular immunology.
[20] A. Mccarthy,et al. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa , 2006, BMC infectious diseases.
[21] H. Gewurz,et al. Mannose binding lectin (MBL) and HIV. , 2005, Molecular immunology.